Bin Cheng Selected Research

4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)

1/2019	Mesenchymal stem cells participate in oral mucosa carcinogenesis by regulating T cell proliferation.
2/2016	Modulation of IL-1β reprogrammes the tumor microenvironment to interrupt oral carcinogenesis.
7/2009	p16(CDKN2A) expression during rat tongue carcinogenesis induced by 4-nitroquinoline-1-oxide.
2/2007	Frequent mutation of p16(CDKN2A) exon 1 during rat tongue carcinogenesis induced by 4-nitroquinoline-1-oxide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bin Cheng Research Topics

Disease

60	Neoplasms (Cancer) 06/2022 - 06/2004
30	Squamous Cell Carcinoma of Head and Neck 01/2022 - 08/2004
19	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2002
18	Carcinogenesis 04/2022 - 04/2004
13	Neoplasm Metastasis (Metastasis) 02/2022 - 10/2006
11	Oral Lichen Planus 01/2022 - 03/2005
8	Heart Failure 11/2022 - 05/2012
8	Inflammation (Inflammations) 10/2022 - 10/2010
7	Infections 01/2022 - 07/2008
7	Wounds and Injuries (Trauma) 01/2022 - 01/2011
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2019 - 04/2003
6	Pain (Aches) 01/2022 - 03/2012
5	Spinal Cord Ischemia 08/2019 - 03/2006
5	Carcinoma (Carcinomatosis) 03/2018 - 04/2003
5	Left Ventricular Dysfunction 02/2014 - 01/2013
4	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 03/2017
4	Hypertension (High Blood Pressure) 01/2021 - 08/2015
4	Reperfusion Injury 08/2019 - 06/2006
4	Periodontitis 01/2019 - 06/2012
4	Mouth Neoplasms (Oral Cancer) 04/2018 - 07/2013
3	Hypoxia (Hypoxemia) 01/2022 - 01/2008
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 02/2021
3	Yang Deficiency (Xu, Yang) 01/2022 - 01/2012
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2021 - 01/2021
3	Hodgkin Disease (Hodgkin's Disease) 12/2020 - 01/2018
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019 - 01/2008
3	Lymphoma (Lymphomas) 01/2018 - 04/2011
3	Ischemia 04/2011 - 06/2006
2	Fibrosis (Cirrhosis) 04/2022 - 12/2018
2	Yin Deficiency (Yinxu) 01/2022 - 05/2019
2	Obesity 10/2021 - 01/2019
2	Myocardial Ischemia (Ischemic Heart Diseases) 07/2021 - 02/2019
2	COVID-19 03/2021 - 01/2021
2	Adenocarcinoma 01/2021 - 04/2014
2	Atherosclerosis 01/2021 - 10/2010
2	Myocardial Infarction 01/2021 - 02/2019
2	Acute Lung Injury 01/2021 - 01/2018
2	Non-alcoholic Fatty Liver Disease 01/2021 - 09/2016
2	Cognitive Dysfunction 09/2020 - 01/2016
2	Osteoarthritis 03/2020 - 07/2019
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 11/2022 - 04/2003
14	Messenger RNA (mRNA)IBA 10/2021 - 01/2002
13	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2007
11	Biological ProductsIBA 10/2022 - 05/2009
7	CytokinesIBA 01/2021 - 03/2005
6	LigandsIBA 01/2022 - 04/2011
6	Pharmaceutical PreparationsIBA 01/2021 - 04/2011
6	hepatitis B virus X proteinIBA 10/2014 - 12/2010
5	CateninsIBA 04/2022 - 02/2016
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2016
4	Long Noncoding RNAIBA 04/2022 - 01/2017
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 10/2002
4	LipopolysaccharidesIBA 10/2021 - 06/2012
4	Interleukin-6 (Interleukin 6)IBA 10/2020 - 03/2005
4	4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA 01/2019 - 02/2007
4	salicylhydroxamic acid (SHAM)IBA 01/2018 - 06/2006
4	Warfarin (Coumadin)FDA LinkGeneric 01/2016 - 07/2011
4	DNA Repair EnzymesIBA 02/2010 - 06/2004
3	InflammasomesIBA 06/2022 - 11/2020
3	Chemokine ReceptorsIBA 01/2022 - 04/2011
3	ChemokinesIBA 01/2022 - 04/2011
3	heparanaseIBA 02/2021 - 01/2017
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2013
3	Indicators and Reagents (Reagents)IBA 01/2021 - 05/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 08/2009
3	Receptor for Advanced Glycation End ProductsIBA 01/2019 - 08/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2018 - 03/2005
3	CC ChemokinesIBA 02/2018 - 03/2016
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016 - 12/2014
3	NF-kappa B (NF-kB)IBA 01/2007 - 03/2005
2	C-Reactive ProteinIBA 10/2022 - 01/2022
2	GlucosidasesIBA 04/2022 - 11/2021
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2022 - 07/2021
2	Transcription Factors (Transcription Factor)IBA 10/2021 - 01/2021
2	Bleomycin (Blenoxane)FDA LinkGeneric 10/2021 - 01/2021
2	Tyrosine (L-Tyrosine)FDA Link 10/2021 - 01/2018
2	Immunoglobulins (Immunoglobulin)IBA 10/2021 - 12/2018
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 07/2021 - 07/2009
2	Ethanol (Ethyl Alcohol)IBA 04/2021 - 03/2020
2	sapanisertibIBA 01/2021 - 10/2019
2	Interleukin-4 (Interleukin 4)IBA 01/2021 - 02/2008
2	oxidized low density lipoproteinIBA 01/2021 - 01/2021
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 10/2019
2	LipidsIBA 01/2021 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2021
2	Brentuximab VedotinIBA 12/2020 - 01/2018
2	Bendamustine Hydrochloride FDA Link 12/2020 - 01/2018
2	DiterpenesIBA 11/2020 - 04/2018
2	Metformin (Glucophage)FDA LinkGeneric 10/2020 - 01/2019
2	abemaciclibIBA 10/2020 - 01/2017
2	Lactic Acid (Lactate)FDA LinkGeneric 10/2020 - 02/2018

Therapy/Procedure

21	Therapeutics 04/2022 - 07/2006
8	Immunotherapy 01/2022 - 01/2019
8	Cardiac Resynchronization Therapy 10/2015 - 05/2012
6	Drug Therapy (Chemotherapy) 01/2019 - 08/2015
4	Radiotherapy 01/2018 - 01/2008
4	Cardiopulmonary Bypass (Heart-Lung Bypass) 02/2014 - 05/2012
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 05/2019
2	Length of Stay 01/2021 - 10/2019